Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Clinuvel Pharmaceuticals Limited
  6. News
  7. Most relevant
    CUV   AU000000CUV3

CLINUVEL PHARMACEUTICALS LIMITED

(CUV)
  Report
End-of-day quote. End-of-day quote Australian Stock Exchange - 10/18
40.48 AUD   -1.53%
10/17CLINUVEL PHARMACEUTICALS : Investor Webinar
PU
10/06CLINUVEL PHARMACEUTICALS : Operations Update Webcast II
PU
10/05Australia shares nearly flat as financials' losses offset tech, healthcare gains
RE
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CLINUVEL PHARMACEUTICALS LIMITED
10/17CLINUVEL PHARMACEUTICALS : Investor Webinar
PU
10/06CLINUVEL PHARMACEUTICALS : Operations Update Webcast II
PU
10/05Australia shares nearly flat as financials' losses offset tech, healthcare gains
RE
10/05CLINUVEL PHARMACEUTICALS : Secures Clearances for Phase Two Study of DNA Repair Drug
MT
10/04CLINUVEL PHARMACEUTICALS : Progresses DNA Repair Program
PU
10/04Clinuvel Pharmaceuticals Limited Receives the Necessary Regulatory and Ethics Committee..
CI
09/22CLINUVEL PHARMACEUTICALS : Key Events and Announcements
PU
09/21CLINUVEL PHARMACEUTICALS : Confirms AGM Date
PU
09/13CLINUVEL PHARMACEUTICALS : Presentation H.C. Wainwright Global Investment Conference
PU
09/02CLINUVEL PHARMACEUTICALS LIMITED : Ex-dividend day for final dividend
FA
08/26CLINUVEL PHARMACEUTICALS : Investor Webinar Financial Results
PU
08/26CLINUVEL PHARMACEUTICALS' : Net Profit Jumps 64% on Higher Drug Demand
MT
08/25CLINUVEL PHARMACEUTICALS : Newsletter 4 - August 2021
PU
08/25CLINUVEL PHARMACEUTICALS : Corporate Presentation - FY2021 Results
PU
08/25CLINUVEL PHARMACEUTICALS : Delivers Record Revenues and Profit
PU
08/25Clinuvel Pharmaceuticals Limited Declares Annual Unfranked Dividend for the Year Ending..
CI
08/25CLINUVEL PHARMACEUTICALS : Appendix 4E and Preliminary Financial Report
PU
08/25Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended June ..
CI
08/10CLINUVEL PHARMACEUTICALS' : Neuroprotective Drug Achieves High Tolerance in Stroke Patient..
MT
08/09CLINUVEL PHARMACEUTICALS : Afamelanotide well tolerated by first stroke patients
PU
08/09CLINUVEL Afamelanotide Tolerates by First Stroke Patients
CI
07/30CLINUVEL PHARMACEUTICALS : Books $11 Million Cash Receipts in Fiscal Q4
MT
06/07CLINUVEL PHARMACEUTICALS : Treats First Patient in Phase 2 Study of Stroke Drug; Shares Fa..
MT
06/06CLINUVEL PHARMACEUTICALS : Media release - First stroke patient with afamelanotide
PU
06/06CLINUVEL PHARMACEUTICALS : First stroke patient treated with afamelanotide
PU
06/06Clinuvel Pharmaceuticals Limited Announces First Stroke Patient Treated with Afamelanot..
CI
06/03CLINUVEL PHARMACEUTICALS : Presentation to Jefferies Healthcare Conference
PU
06/02CLINUVEL PHARMACEUTICALS : Newsletter 3 - June 2021
PU
04/28CLINUVEL PHARMACEUTICALS : Appendix 4C - quarterly
PU
04/11CLINUVEL PHARMACEUTICALS : Strategic Update II - April 2021
PU
03/31CLINUVEL PHARMACEUTICALS : Newsletter II - April 2021
PU
03/24CLINUVEL PHARMACEUTICALS : Media Release - CLINUVEL expands DNA Repair Program
PU
03/24CLINUVEL PHARMACEUTICALS : SCENESSE to be assessed in xeroderma pigmentosum variant XPV
PU
03/23CLINUVEL expands DNA Repair Program
GL
03/23CLINUVEL Expands DNA Repair Program
CI
03/09CLINUVEL PHARMACEUTICALS : Presentation - Daiwa Investment Conference Tokyo 2021
PU
02/28Australia shares climb 1.5% as country inches towards pre-pandemic normal
RE
02/24CLINUVEL PHARMACEUTICALS : Operations Update Webinar Released
PU
02/23CLINUVEL PHARMACEUTICALS : Reports Tenth Consecutive Half Year Profit
PU
02/23CLINUVEL PHARMACEUTICALS : Appendix 4D Half Yearly Report
PU
02/23Clinuvel Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended Decem..
CI
02/11CLINUVEL PHARMACEUTICALS' : Light Toxicity Treatment Receives Market Access Approval in Is..
MT
02/10CLINUVEL PHARMACEUTICALS : SCENESSE Granted Market Access in Israel
PU
01/27CLINUVEL PHARMACEUTICALS : Appendix 4C - quarterly
PU
01/24CLINUVEL PHARMACEUTICALS : Newsletter
PU
2020CLINUVEL PHARMACEUTICALS : Appendix 3G
PU
2020CLINUVEL PHARMACEUTICALS : Newsletter
PU
2020CLINUVEL PHARMACEUTICALS : SCENESSE DNA Repair Study Approved to Commence
PU
2020Clinuvel Pharmaceuticals Limited Receives Approval to Commence a New Study Assessing th..
CI
2020CLINUVEL PHARMACEUTICALS : Presentation Jefferies Virtual London Healthcare Conference
PU
2020CLINUVEL PHARMACEUTICALS : Chair Letter
PU
2020CLINUVEL PHARMACEUTICALS : Results of Meeting
PU
2020CLINUVEL PHARMACEUTICALS : Chair Address
PU
2020CLINUVEL PHARMACEUTICALS : Managing Directors AGM Presentation
PU
2020CLINUVEL PHARMACEUTICALS : Strategic Update – Executive Summary
PU
2020CLINUVEL PHARMACEUTICALS : Strategic Update - Extended
PU
2020CLINUVEL PHARMACEUTICALS : Strategic Update - Executive Summary
PU
2020CLINUVEL PHARMACEUTICALS : Appendix 4C - quarterly
PU
2020CLINUVEL PHARMACEUTICALS : to Trial Innovative Drug in Stroke
AQ
2020CLINUVEL to Trial Innovative Drug in Stroke
GL
2020CLINUVEL to Trial Innovative Drug in Stroke
CI
2020CLINUVEL PHARMACEUTICALS : Media Release - CLINUVEL to Trial Innovative Drug in Stroke
PU
2020CLINUVEL PHARMACEUTICALS : afamelanotide for Acute Stroke Patients
PU
2020Clinuvel Pharmaceuticals Limited Announces Evaluation the Effects of Its Drug afamelano..
CI
2020CLINUVEL PHARMACEUTICALS : Media Release - TGA approves SCENESSE
PU
2020CLINUVEL PHARMACEUTICALS : Australian TGA approves SCENESSE
PU
2020Clinuvel Pharmaceuticals Limited Receives Approval in Australia for a Rare Light Intole..
CI
2020CLINUVEL PHARMACEUTICALS : SCENESSE DNA Repair Update
PU
2020Clinuvel Pharmaceuticals Limited Announces Clinical Update on the Use of Its Drug SCENE..
CI
2020CLINUVEL PHARMACEUTICALS : Further Research Coverage Initiated on CLINUVEL
PU
2020CLINUVEL PHARMACEUTICALS : Presentation - Value in the Vines Investor Conference
PU
2020CLINUVEL PHARMACEUTICALS : Annual General Meeting 2020
PU
2020CLINUVEL PHARMACEUTICALS : Appendix 4G and Corporate Governance Statement
PU
2020CLINUVEL PHARMACEUTICALS : Annual Report to shareholders
PU
2020CLINUVEL PHARMACEUTICALS : Confirms AGM Date
PU
1  2  3  4  5Next
Upcoming event on CLINUVEL PHARMACEUTICALS LIMITED